ImmunoPrecise Antibodies Ltd. filed a Form 6-K on March 20, 2024, to report updates as a foreign private issuer under U.S. securities laws. The filing does not contain any significant quantitative data or material events.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.